ARHGAP21 and prostate adenocarcinoma: In previous research, Lazarini et al. [13] verified that ARHGAP21 modulated the proliferation in prostate adenocarcinoma cells, and it might be attributed to the endothelin-1 signaling pathway, of which its most important members are ARHGAP21 partners.